There are two main conclusions that researchers have come to regarding ADHD. First, ADHD is not a “clear-cut” disorder that is either possessed completely or not at all but rather spread across a scope of impairment. The second conclusion is that the medications frequently used to treat ADHD are highly controversial. In April 2022, a labor lawsuit was filed by a formal Cerebral executive, because his employer had fired him for expressing a large concern about the company. In his words, the company “egregiously put profits and growth before patient safety” by over prescribing medications for ADHD. According to Joy Hui Lin, a freelance journalist in southern California, “The thing is that meds are not a panacea, you need structure” (Korducki).
Embedded Files
While the process of diagnosing ADHD has come a long way, the different treatment methods have been met with controversy. Many people question the authenticity of the disorder itself, and whether it’s even treatable or not. The largest of these controversies is prescription psychostimulants, which are drugs that stimulate the brain. Amphetamine, methylphenidate, and pemoline are the most well-researched and frequently used medications to treat ADHD. However, psychostimulants worry many people because of the possibility of patients misusing or abusing them (“Diagnosis and Treatment”).
Page updated
Report abuse